ICAM1 and inflammatory bowel disease: The results of this study suggested that the overexpression of ICAM-1 could enhance the ability of MSCs to regulate Th cell subsets, promote the migration of MSCs to damaged tissues and reduce the inflammatory response locally, thereby playing a better therapeutic role in IBD.